All articles tagged with #dha
A USC-led trial found that high-dose fish oil increases brain DHA levels by about 17% but does not improve memory, cognition, or hippocampal preservation in older adults at risk for Alzheimer’s, indicating omega-3 supplements are not a standalone preventive measure and that benefits may hinge on diet and overall health patterns rather than supplementation alone.
A two-year, placebo-controlled USC study of 365 adults at elevated risk for Alzheimer’s found that 2,000 mg of DHA from fish oil did not improve memory, cognition, or brain structure, despite higher DHA levels in brain fluid; results suggest fish oil supplements do not prevent Alzheimer’s, and emphasize Mediterranean-style diets and healthy lifestyle as the best defense.
A two-year, double-blind trial found that high-dose DHA from fish oil reached the brain but did not improve memory or cognitive function nor slow hippocampal shrinkage in older adults at risk for Alzheimer's, suggesting supplements may not protect brain health and highlighting the importance of overall diet and lifestyle.
A randomized, double-blind trial found that two years of high-dose DHA supplementation raised brain and blood DHA levels in older adults at risk for dementia, but it did not improve cognitive function or brain structure compared with placebo, even among APOE ε4 carriers. The study suggests DHA alone does not prevent dementia, though omega-3s remain beneficial as part of a balanced diet and brain-healthy lifestyle.
A two-year, placebo-controlled study of 365 older adults at risk for Alzheimer’s found that high-dose DHA omega-3 supplements did not improve memory, cognition, or brain-structure measures, despite DHA reaching the brain; researchers suggest fish oil alone isn’t protective and that dietary patterns (e.g., Mediterranean diet) plus healthy lifestyle may be more effective for brain health.
A mouse study found that EPA, an omega-3 in fish oil, can impair blood vessel repair and worsen cognitive recovery after mild traumatic brain injury, while DHA did not have this effect. EPA also accumulated in the brain and was linked to toxic tau buildup, suggesting a context-dependent risk with EPA-containing supplements. Relevance to humans remains uncertain, but the findings highlight the need for precision nutrition and further trials.
A Cell Reports study in mice with repetitive traumatic brain injuries found that high brain levels of EPA from fish oil can impair blood-vessel repair and increase vulnerability to cognitive decline and abnormal tau buildup, while DHA remained neutral; results are preliminary and mostly in animals, so human relevance is unclear and effects may depend on context.
A MUSC study published in Cell Reports shows that EPA, an omega-3 fatty acid in fish oil, can hinder brain repair after repetitive mild traumatic brain injuries, while DHA remains generally beneficial; in mice and human endothelial cells EPA reduced repair and angiogenesis, with postmortem CTE tissue showing related lipid and vascular changes. The authors caution that omega-3 effects are context-dependent and not universally protective, urging more research into precision nutrition and EPA handling in the brain.
Fish oil supplements contain DHA and EPA, which are essential fatty acids that need to be consumed in the diet. They have numerous health benefits, including reducing inflammation, triglycerides, and blood pressure, as well as improving heart and brain function. However, it's important to consult with a doctor before taking any supplements, as the levels of elements within these supplements can vary widely. Vegetarian alternatives like algae-derived DHA supplements are also available.
Docosahexaenoic acid (DHA) is an omega-3 fatty acid found in fatty fish like salmon, which has many health benefits, including improving heart health, brain function, cognitive development, and eye health. As humans cannot produce enough DHA in the body, it needs to be consumed in the diet or through supplements like fish oil or algae-derived DHA supplements. However, it's essential to consult with a doctor before taking any new supplements, as the levels of DHA may vary among different supplements.
Researchers have developed a new form of omega-3 fatty acid known as docosahexaenoic acid (DHA) that can enter the retinal tissue, which could be used to reduce the risk and potentially treat some retinal diseases. The retina and brain have the highest concentration of DHA, which has to be provided through diet or supplementation. The new form of DHA, called LPC-DHA, has been tested in mice and shown to be superior to other forms of DHA supplementation. Low levels of DHA have been found in the retinas of individuals with age-related macular degeneration, diabetic retinopathy, and Alzheimer's disease.
Researchers have developed a new form of omega-3 fatty acid docosahexaenoic acid (DHA) that can cross into the eye’s retina, potentially helping to prevent visual decline linked to Alzheimer’s disease, diabetes, and other disorders. The newly created lysophospholipid form of DHA (LPC-DHA) was found to be more effective than the typical triacylglycerol (TAG) DHA in fish oil capsules, which cannot reach the eyes. In a study using mice, LPC-DHA increased DHA in the retina and reduced eye problems related to Alzheimer’s-like processes, suggesting a potential novel therapeutic approach for retinal dysfunction associated with Alzheimer’s disease and diabetes.
A new form of the Omega-3 fatty acid DHA, called LPC-DHA, has been developed that can cross the retina in the eye and prevent visual declines related to Alzheimer’s disease, diabetes, and other disorders. LPC-DHA successfully increased DHA in the retina and reduced eye problems associated with Alzheimer’s-like processes in mice. The approach provides a novel therapeutic approach for the prevention or mitigation of retinal dysfunction associated with Alzheimer’s disease and diabetes. Further studies would be needed to confirm that LPC-DHA is safe and effective for use in humans.